Dr. Gang Zheng is a professor and Tier 1 Canada Research Chair in Cancer Nanomedicine at the University of Toronto, and a Senior Scientist and Associate Research Director at the Princess Margaret Cancer Centre.
Dr. Zheng is a world leading innovator in developing nanotechnology-based diagnostic and therapeutic applications for cancer treatment. His revolutionary discovery of porphysome nanotechnology, a world-first, one-for-all cancer nanomedicine that can detect tumors by PET and MRI scans, guide surgery by lighting up tumors, and kill tumors with light or enhanced chemotherapy and radiation, was named one of the “Top Ten Cancer Breakthroughs of 2011” by the Canadian Cancer Society. His outstanding achievements have also earned him the Till and McCulloch Paper of the Year Award, the UHN Inventor of the Year Award, the Radiological Society of North America Research Award, the Joey and Toby Tanenbaum/Brazilian Ball Chair in Prostate Cancer Research, and Fellow of the American Institute of Medical and Biological Engineering, among others.
His research endeavours have led to over 200 peer-reviewed publications, many in such top-tier journals as Nature Materials and Nature Nanotechnology. His works have been cited over 18,000 times, producing an exceptionally high h-index of 71. His patent portfolio comprises 10 granted patent families and 11 filed applications. He was selected as an editor for Bioconjugate Chemistry in 2014 and has served on the editorial boards of 11 international journals. An internationally sought-after speaker, he has given over 180 invited lectures around the world.